Varex Imaging Corporation (VREX) has disclosed a new risk, in the Accounting & Financial Operations category.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Varex Imaging Corporation faces significant financial risk due to potential impairment charges related to its goodwill, which stood at $198.4 million as of October 3, 2025. The company is required to conduct annual tests on intangible assets with indefinite lives, including goodwill, and may need to record impairment charges that could negatively impact earnings or increase losses. A recent example includes a $93.9 million goodwill impairment charge recorded for its Medical reporting unit, driven by factors such as a decrease in stock price and market capitalization, as well as external pressures like tariffs and MOFCOM Investigations. The sensitivity of their goodwill impairment analysis to key assumptions suggests that further impairment charges could occur, posing a threat to the company’s financial health and operational results.
Overall, Wall Street has a Moderate Buy consensus rating on VREX stock based on 2 Buys and 1 Hold.
To learn more about Varex Imaging Corporation’s risk factors, click here.